Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Verma

Showing results (381-390 of 459) with videos related to

Pageof 46
Sort By:
Nature Cell Biology|April 24, 2019
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesMolly A Smith, Gaurav S Choudhary, Andrea Pellagatti, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
Experimental Hematology & Oncology|July 8, 2023
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative reviewCharan Thej Reddy Vegivinti, Praneeth Reddy Keesari, Sindhusha Veeraballi, et al.
Molecular Cell|March 23, 2024
Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscapePrajwal C Boddu, Abhishek K Gupta, Rahul Roy, et al.
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic SyndromesValeria Santini, David Valcárcel, Uwe Platzbecker, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activationMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Pageof 46

Showing results (381-390 of 459) with videos related to

Sort By:
Pageof 46
Nature Cell Biology|April 24, 2019
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesMolly A Smith, Gaurav S Choudhary, Andrea Pellagatti, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
Experimental Hematology & Oncology|July 8, 2023
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative reviewCharan Thej Reddy Vegivinti, Praneeth Reddy Keesari, Sindhusha Veeraballi, et al.
Molecular Cell|March 23, 2024
Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscapePrajwal C Boddu, Abhishek K Gupta, Rahul Roy, et al.
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic SyndromesValeria Santini, David Valcárcel, Uwe Platzbecker, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activationMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Pageof 46